Accessibility Menu
 

Range Impact

(OTC) VBIO

Current PriceN/A
Market CapN/A
Since IPO (2012)-98%
5 Year-38%
1 Year-10%
1 Month-6%

Range Impact Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$778.77K

Net Income (TTM)

$2.11M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

VBIO News

No articles available.

VBIO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Range Impact

Industry

Commercial Services and Supplies

Employees

10

CEO

Michael Cavanaugh, MBA

Headquarters

Los Angeles, CA, US

VBIO Financials

Key Financial Metrics (TTM)

Gross Margin

-1%

Operating Margin

-62%

Net Income Margin

36%

Return on Equity

26%

Return on Capital

-4%

Return on Assets

2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$2.34M

EBITDA

$880.85K

Operating Cash Flow

$1.61M

Capital Expenditure

$0.00

Free Cash Flow

$1.61M

Cash & ST Invst.

$884.14K

Total Debt

$0.00

Range Impact Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$778.77K

N/A

Gross Profit

$191.73K

N/A

Gross Margin

-24.62%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

3

N/A

Net Income

$633.38K

-191.4%

EBITDA

$570.55K

-182.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$14.61K

-101.0%

Accounts Receivable

$447.16K

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$300.00K

+1193.4%

Return on Assets

2.14%

N/A

Return on Invested Capital

-3.91%

N/A

Free Cash Flow

$964.82K

+1008.6%

Operating Cash Flow

$964.82K

+1008.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OCELOrganicell Regenerative Medicine, Inc.
$2.74-0.27%
OPBXFOptiBiotix Health Plc
$0.22+0.00%
KMSTFKadimastem Ltd
$3.21-3.02%
EMMLFOKYO Pharma Limited
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About VBIO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.